Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease. Kurata Y, Tanaka T, Nangaku M. Curr Opin Nephrol Hypertens 2020;29:414-422.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kurata Y, Tanaka T, Nangaku M. Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease. Curr Opin Nephrol Hypertens 2020;29:414-422.
PMID: 32452915